Cited by 233Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesSmoking Behavior and Cessation

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.

Open access

Levin, Frances R., Mariani, John J., Brooks, Daniel J., Pavlicova, Martina, Cheng, Wendy, Nunes, Edward V.·2011·Drug and Alcohol Dependence

DOI 10.1016/j.drugalcdep.2010.12.010PMC PMC3154755

Open this paper in CoChat — free account

Abstract

Cannabis dependence is a substantial public health problem. Behavioral treatments have shown promise, but there are no effective medications for cannabis dependence. The purpose of this study was to evaluate the safety and efficacy of dronabinol, a synthetic form of delta-9-tetrahydrocannabinol, a naturally occurring pharmacologically active component of marijuana, in treating cannabis dependence. 156 cannabis-dependent adults were enrolled in a randomized, double-blind, placebo-controlled, 12-week trial. After a 1-week placebo lead-in phase, participants were randomized to receive dronabinol 20mg twice a day or placebo. Doses were maintained until the end of week 8 and then tapered off over 2 weeks. All participants received weekly motivational enhancement and relapse prevention therapy. Marijuana use was assessed using the timeline follow back method. There was no significant difference between treatment groups in the proportion of participants who achieved 2 weeks of abstinence at the end of the maintenance phase (dronabinol: 17.7%; placebo: 15.6%). Although both groups showed a reduction in marijuana use over time, there were no differences between the groups. Treatment retention was significantly higher at the end of the maintenance phase on dronabinol (77%), compared to placebo (61%) (P=.02), and withdrawal symptoms were significantly lower on dronabinol than placebo (P=.02). This is the first trial using an agonist substitution strategy for treatment of cannabis dependence. Dronabinol showed promise, it was well-tolerated, and improved treatment retention and withdrawal symptoms. Future trials might test higher doses, combinations of dronabinol with other medications with complementary mechanisms, or with more potent behavioral interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2010.12.010

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Timeline Follow-Back
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
Diagnostic and Statistical Manual of Mental Disorders
Raber, G., & Spokas, M. (2024) · doi:10.4135/9781071886229.n145 · Cited by 2,806
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,564
Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials
Dennis, M. L., Godley, S. H., Diamond, G., Tims, F. M., Babor, T. F., Donaldson, J., Liddle, H. A., Titus, J. C., Kaminer, Y., Webb, C. P. M., et al. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2003.09.005 · Cited by 780
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub3 · Cited by 721 · cited 2×
“…varenicline, methadone, buprenorphine) reduce withdrawal symptoms, improve treatment retention, reduce the reinforcing effects of the addictive drug, and promote abstinence (Comer et al., 2001; Garrison and Dugan, 2009; Mattick et al., 2009; Schottenfeld et al., 2008; Stead et al., 2008).”
Background
Comparison of extended versus brief treatments for marijuana use.
Stephens, R. S., Roffman, R. A., & Curtin, L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.5.898 · Cited by 711
Prevalence of Marijuana Use Disorders in the United States: 1991-1992 and 2001-2002
Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004) · JAMA · doi:10.1001/jama.291.17.2114 · Cited by 537

Show all 64 references

Sorted by citations

Items 101–200 of 233

Screening Medications for the Treatment of Cannabis Use Disorder
Panlilio, L. V., Justinová, Z., Trigo, J. M., & Foll, B. L. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.005 · Cited by 18
Minding the brain: the role of pharmacotherapy in substance-use disorder treatment
Dakwar, E., & Kleber, H. D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/hkleber · Cited by 17
Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges
Tijani, A. O., Garg, J., Frempong, D., Verana, G., Kaur, J., Joga, R., Sabanis, C. D., Kumar, S., Kumar, N., & Puri, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.034 · Cited by 18
Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents
Nielsen, S., Sabioni, P., Gowing, L., & Foll, B. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_258 · Cited by 17
Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials
Vuilleumier, C., Scherbaum, N., Bonnet, U., & Roser, P. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.867878 · Cited by 16
Treatment of Adolescent Cannabis Use Disorders
Adams, Z. W., Marriott, B. R., Hulvershorn, L. A., & Hinckley, J. D. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.07.006 · Cited by 17
Integrative Pharmacology in the Treatment of Substance Use Disorders
Donlon, J., Kumari, P., Varghese, S. P., Bai, M. Y., Florentin, O. D., Frost, E. D., Banks, J., Vadlapatla, N., Kam, O., Shad, M. U., et al. (2023) · Journal of Dual Diagnosis · doi:10.1080/15504263.2023.2293854 · Cited by 15
New Developments in Understanding and Treating Adolescent Marijuana Dependence
Gray, K. M. (2014) · Adolescent Psychiatry · doi:10.2174/221067660304140121173215 · Cited by 15
Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
Thomsen, K. R., Thylstrup, B., Kenyon, E. A., Lees, R., Baandrup, L., Ewing, S. W. F., & Freeman, T. P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.033 · Cited by 15
Guideline No. 425b: Cannabis Use Throughout Women’s Lifespans – Part 2: Pregnancy, the Postnatal Period, and Breastfeeding
Graves, L. E., Robert, M., Allen, V. M., Dama, S., Gabrys, R. L., Tanguay, R. L., Turner, S. D., Green, C. R., & Cook, J. L. (2022) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2022.01.013 · Cited by 17
Individual mindfulness‐based psychotherapy for cannabis or cocaine dependence: A pilot feasibility trial
Dakwar, E., & LEVIN, F. R. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12036.x · Cited by 16
Self-citation
Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking
Martin, E. L., Doncheck, E. M., Reichel, C. M., & McRae‐Clark, A. L. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100364 · Cited by 14
Oral Fluid Cannabinoids in Chronic Cannabis Smokers during Oral Δ9-Tetrahydrocannabinol Therapy and Smoked Cannabis Challenge
Lee, D., Vandrey, R. G., Mendu, D. R., Anizan, S., Milman, G., Murray, J. A., Barnes, A. J., & Huestis, M. A. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.207316 · Cited by 14
The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists
Imperio, C. G., LEVIN, F. R., & Martínez, D. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20231023 · Cited by 15
Self-citation
The differential effects of medicinal cannabis on mental health: A systematic review
de Bode, N., Kroon, E., Sznitman, S. R., & Cousijn, J. (2025) · Clinical Psychology Review · doi:10.1016/j.cpr.2025.102581 · Cited by 13
When and How to Treat Possible Cannabis Use Disorder
Lévesque, A., & Foll, B. L. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.009 · Cited by 13
Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?
Tibbo, P. G., McKee, K. A., Meyer, J. H., Crocker, C. E., Aitchison, K. J., Lam, R. W. M., & Crockford, D. N. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720945525 · Cited by 13
Pharmacotherapies for cannabis use disorder
Spiga, F., Parkhouse, T., Tang, V. M., Savović, J., Foll, B. L., & Nielsen, S. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub4 · Cited by 12
Verbal learning in marijuana users seeking treatment: a comparison between depressed and non-depressed samples
Roebke, P. V., Vadhan, N. P., Brooks, D. J., & LEVIN, F. R. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.875551 · Cited by 12
Self-citation
Substance Abuse/Dependence Treatment: A European Perspective
Metz, V. E., Brandt, L., Unger, A., & Fischer, G. (2014) · Substance Abuse · doi:10.1080/08897077.2014.909377 · Cited by 12
Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders
Martins, B. S., Rutland, W., Aquino, J. P. D., Kazer, B., Funaro, M. C., Potenza, M. N., & Angarita, G. A. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00432-9 · Cited by 12
Network-Assisted Prediction of Potential Drugs for Addiction
Sun, J., Huang, L., Xu, H., & Zhao, Z. (2014) · BioMed Research International · doi:10.1155/2014/258784 · Cited by 11
Unveiling the link between chronic pain and misuse of opioids and cannabis
Dagher, M., Alayoubi, M., Sigal, G. H., & Cahill, C. M. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02765-3 · Cited by 11
Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice
Eckard, M. L., & Kinsey, S. G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108554 · Cited by 10
Impact of cyclooxygenase‐2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers
Haney, M., Bedi, G., Cooper, Z. D., Herrmann, E. S., Collins, S. L., Foltin, R. W., Kingsley, P. J., Marnett, L. J., & Patel, S. (2022) · Addiction Biology · doi:10.1111/adb.13183 · Cited by 10
Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders
Royse, S. K., Lopresti, B. J., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15657 · Cited by 10
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
Mills, L., Dunlop, A. J., Montebello, M. E., Copeland, J., Bruno, R., Jefferies, M., McGregor, I. S., & Lintzeris, N. (2022) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-022-00493-z · Cited by 9
Prediction of adverse events risk in patients with comorbid post-traumatic stress disorder and alcohol use disorder using electronic medical records by deep learning models
Miranda, O., Fan, P., Qi, X., Wang, H., Brannock, D., Kosten, T. R., Ryan, N. D., Kirisci, L., & Wang, L. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111066 · Cited by 9
Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates
Kangas, B. D., Zakarian, A. S., Vemuri, K. V., Alapafuja, S. O., Jiang, S. H., Nikas, S. P., Makriyannis, A., & Bergman, J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.261818 · Cited by 9
Management of withdrawal from alcohol and other drugs
Lintzeris, N., Sunjic, S., Demirkol, A., Branezac, M., Ezard, N., Siefried, K. J., Acheson, L. S., Bascombe, F., Tremonti, C., & Haber, P. (2019) · doi:10.57022/mjjp9930 · Cited by 9
Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology
Sinclair, J., Kalk, N. J., Kaar, S. J., Agabio, R., Arunogiri, S., Bisaga, A. M., Chesney, E., Daly, C., Dewhurst, J., Freeman, T. P., et al. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251399593 · Cited by 10
Cannabidiol Compared to Pharmacological Treatment as Usual for Crack Use Disorder: A Feasibility, Preliminary Efficacy, Parallel, Double-Blind, Randomized Clinical Trial
Gallassi, A. D., de Oliveira, A. W. C., Rodrigues, L. A., Nakano, E. Y., Ruas, P. A. S., Mata, J. A. I. D. L., Júnior, E. F., Gomes, J. D. A., Caroba, M. E. S., Silva, M., et al. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01287-z · Cited by 10
Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder
Martin, E. L., & McRae‐Clark, A. L. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00342-8 · Cited by 8
A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.
Little, R., & D’Mello, D. A. (2022) · PubMed Central · Cited by 8
Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting
Lam, P. W., & Frost, D. (2014) · BMJ Case Reports · doi:10.1136/bcr-2014-205287 · Cited by 8
Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action
Alayoubi, M., Henry, B. A., Cahill, C. M., & Cooper, Z. D. (2024) · Drugs · doi:10.1007/s40265-024-02098-1 · Cited by 7
Novel Pharmacotherapeutic Interventions for Cannabis Use Disorder
Mason, B. L., Mustafa, A., Filbey, F. M., & Brown, E. S. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0094-y · Cited by 7
Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach
Gharbi, K. A., Bonomo, Y. A., & Hallinan, C. M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054087 · Cited by 7
Behavioral Interventions and Pharmacotherapies for Cannabis Use Disorder
Bobb, A. J., & Hill, K. P. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0013-6 · Cited by 7
Cannabinoids for Substance Use Disorder Treatment: What Does the Current Evidence Say?
Fernandes, J. A. B., Filev, R., & Fidalgo, T. M. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0065 · Cited by 6
Human Laboratory Models of Cannabis Use Disorder
Arout, C. A., Herrmann, E. S., & Haney, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_9 · Cited by 6
Considerations for Anesthesia in Older Adults with Cannabis Use
Ahrens, E., Wachtendorf, L. J., Hill, K. P., & Schaefer, M. S. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01161-6 · Cited by 5
Cannabinoid Hyperemesis Syndrome (CHS) - An emerging gastrointestinal disorder and clinical challenge
McFee, R. B. (2024) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101832 · Cited by 5
NEUROSCIENTIFIC BASIS OF TREATMENT FOR SUBSTANCE USE DISORDERS
Bozkurt, M. (2022) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.28172 · Cited by 7
The Treatment of Cannabis Use Disorder
Danovitch, I., & Gorelick, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54856-4.00007-9 · Cited by 5
Treatment of Cannabis Use Disorders
Ramesh, D., & Haney, M. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_14 · Cited by 5
Unravelling the landscape of Cannabis craving pharmacological treatments: a PRISMA-guided review of evidence
Preto, M. C., Kortas, G. T., Blaas, I. K., Lassi, D. L. S., Campos, M. W., Torales, J. C., Ventriglio, A., Périco, C. D. A.-M., de Andrade, A. G., & Castaldelli-Maia, J. M. (2023) · International Review of Psychiatry · doi:10.1080/09540261.2023.2231540 · Cited by 4
Treatment of Adolescent Cannabis Use Disorders
Adams, Z. W., Marriott, B. R., Hulvershorn, L. A., & Hinckley, J. D. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.03.004 · Cited by 4
Addiction and Liver Disease: Exploring the Complex Relationship and Implications for Clinical Management
Hudson, D., Howarth, N., Idalsoaga, F. J., Song, Y. N., Islam, A. H., Theiventhiran, S., Díaz, L. A., & Arab, J. P. (2024) · Current Hepatology Reports · doi:10.1007/s11901-024-00630-1 · Cited by 4
Update on the Neuropsychiatry of Substance Use Disorders
Kolodner, G., & Koliatsos, V. E. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.011 · Cited by 3
Pharmacological Treatment of Substance Abuse Disorders
Raby, W. N., Mariani, J. J., LEVIN, F. R., & Nunes, E. V. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch113 · Cited by 4
Self-citation
Relationships between cannabis use and mental disorders: assessing the coherence of evidence from studies with different methodologies
Hall, W., Mekonen, T., Lees, R., Hoch, E., Burke, C., Gridley, A., Hurd, Y. L., Wilson, J., Leung, J., & Freeman, T. P. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(26)00086-6 · Cited by 4
Beyond abstinence: Redefining success in cannabis use disorder treatment
Atkin, T., LEVIN, F. R., MARIANI, J., & Brezing, C. (2026) · Addiction · doi:10.1111/add.70517 · Cited by 3
Self-citation
Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial
Walters, K. J., Baker, N. L., Tomko, R. L., Gray, K. M., Carpenter, M. J., & McClure, E. A. (2023) · BMC Psychology · doi:10.1186/s40359-023-01060-2 · Cited by 3
Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial
Morley, K. C., Haber, Morgan, & Samara (2012) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s30052 · Cited by 3
Cannabinoids for the treatment of cannabis abuse disorder
Rodríguez, A., & Zavala, C. (2018) · Medwave · doi:10.5867/medwave.2018.06.7286 · Cited by 3
Cannabinoid Drugs in Mental Health Disorders
Kloiber, S. M., Matheson, J., Kim, H. K., & Foll, B. L. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_465-1 · Cited by 3
Treatment Strategies for Cannabis Use in Schizophrenia
Schultz, B., Rodriguez-Cabezas, L., Angres, D., & Smith, M. J. (2015) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-015-0043-8 · Cited by 3
Cannabis Withdrawal
Schlienz, N. J., & Vandrey, R. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_11 · Cited by 3
Pharmacological and Integrated Treatments in Older Adults with Substance Use Disorders
Mannelli, P., Wu, L.-T. T., & Brady, K. T. (2014) · Wiley eBooks · doi:10.1002/9781118430965.ch20 · Cited by 3
Effects of repeated cue exposure on cannabis craving
Fogel, J. S., Kelly, T. H., Harvanko, A. M., & Lile, J. A. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.07.1111 · Cited by 2
Cannabisgebrauch bei Jugendlichen
Skala, K., Trabi, T., Fuchs, M., Gößler, R., Haas-Stockmair, C.-W., Kriechbaumer, N., Leitner, M., Ortner, N., Reiter, M., Müller, C., et al. (2022) · Neuropsychiatrie · doi:10.1007/s40211-022-00424-1 · Cited by 2
Cannabiskonsum und Cannabiskonsumstörungen
Hoch, E., & Preuss, U. W. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01722-5 · Cited by 2
Cannabinoid-based Pharmacology for the Management of Substance Use Disorders
Luján, M. Á., Kim, Y., Zhang, L., & Cheer, J. F. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_551 · Cited by 2
Cannabidiol and Cannabis Use Disorder
García‐Gutiérrez, M. S., Navarrete, F., Viudez‐Martínez, A., Gasparyan, A., Caparrós, E., & Manzanares, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_5 · Cited by 2
The Molecular Basis of Cannabinoid Activity: Application to Therapeutics Design and Discovery for Cannabis Use Disorders
Janero, D. R., Vemuri, K. V., & Makriyannis, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_6 · Cited by 2
Empirical Analysis of the Volatility of Stock Market Based on the Improved GARCH Model
祝, 人. (2020) · Advances in Applied Mathematics · doi:10.12677/aam.2020.92017 · Cited by 2
Pharmacological management of psychoactive substance withdrawal syndrome
Fluyau, D., Cook, S., Chima, A., Kailasam, V. K., & Revadigar, N. (2021) · Drugs & Therapy Perspectives · doi:10.1007/s40267-021-00874-7 · Cited by 2
Revisión del tratamiento del uso conjunto del tabaco y del cannabis
Herrera, A. E., Olano-Espinosa, E., Arnedillo, J. J. M., Ogué, C. P., & Duaso, M. J. (2019) · INFORMACIO PSICOLOGICA · doi:10.14635/ipsic.2019.117.6 · Cited by 1
Adolescent Cannabis Use Disorder
Lundahl, L. H., & Ledgerwood, D. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-87990-6_13 · Cited by 1
Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models
Bedillion, M. F., Moore, C. F., Weerts, E. M., Arout, C. A., Harris, H. M., & Haney, M. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_598 · Cited by 1
New Horizons in the Development of Treatments for Substance Use Disorders
Mariani, J. J., & LEVIN, F. R. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20260362 · Cited by 1
Self-citation
Overview of Cannabis Use, Misuse, and Addiction
Stern, C. A. J., Bertoglio, L. J., & Takahashi, R. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00061-4 · Cited by 1
The Treatment of Cannabis Use Disorder Among Individuals With a Psychotic Disorder
Bosanac, P., Lusicic, A., & Castle, D. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00013-6 · Cited by 1
Translation of CUD Therapeutics from Drug Discovery to the Clinic
Hampson, A. J., & Walsh, R. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_7 · Cited by 1
Cannabis: consumo, efectos y consideraciones sobre legalización y tratamiento
Castillo-Toledo, C., Gutiérrez-Rojas, L., Molina-Ruiz, R. M., & Álvarez-Mon, M. Á. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.12.003 · Cited by 2
Cannabinoids to Treat Cannabis Use Disorders
Brezing, C., & LEVIN, F. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_19 · Cited by 1
Self-citation
Directive clinique no 425b : Le cannabis aux différentes périodes de la vie des femmes — Partie 2 : Grossesse, période postnatale et allaitement
Graves, L. E., Robert, M., Allen, V. M., Dama, S., Gabrys, R. L., Tanguay, R. L., Turner, S. D., Green, C. R., & Cook, J. L. (2022) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2022.02.012 · Cited by 1
Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Dual Nicotine and Cannabis Dependence: A Pilot Study
Hill, K. P., Toto, L. H., Lukas, S. E., Weiss, R. D., Trksak, G. H., Rodolico, J. M., & Greenfield, S. F. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12007.x · Cited by 1
Substance Abuse: Cannabis‐Related Disorders
Nordstrom, B. R., Akerman, S. C., & LEVIN, F. R. (2015) · doi:10.1002/9781118753378.ch74
Self-citation
Recent advances in pharmacological management of substance use disorders
Kar, S. K., & Sharma, D. (2015) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/2231-0738.167505 · Cited by 1
Changes of endocannabinoid plasma levels following type I trauma
von Heimendahl, J. (2012)
With pot now legal, therapies sought to blunt high of marijuana
Owens, B. (2014) · Nature Medicine · doi:10.1038/nm0214-107
A retrospective outcomes evaluation of cannabis use at an addictions center
Kovac, G., Abbasi, Y., & Owens, D. (2015) · Drugs and Alcohol Today · doi:10.1108/dat-10-2014-0036
Cannabinoids Overview: Medical Use, Abuse, Pharmacotherapy, and Assessment of Consequences
Teter, C. J. (2014)
Changes of endocannabinoid plasma levels following type I trauma: A prospective pilot study
Falkai, P. (2012)
Pharmacotherapies for Cannabis Use Disorders
McRae‐Clark, A. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00124-1
Cannabis Use Disorders in Primary Care: Screening and Treatment Suggestions
Turner, S., Nader, M., & Graves, L. E. (2017) · Medical Research Archives · doi:10.18103/mra.v5i7.1309
Pharmacologic Management of Comorbid Post-Traumatic Stress Disorder and Addictions
Shorter, D. I., Hsieh, J. J., & Kosten, T. R. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.150405
Innovative pharmakologische Ansätze zur Behandlung von Suchterkrankungen
Majić, T., Gutwinski, S., Müller, C. A., Schoofs, N., & Heinz, A. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00006-0
The Research Progress of Treatment of Several Mental Disorders Using Cannabis Drugs (THC and CBD)
周, 小. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.102020
Cannabis in Palliative Medicine
Saint-Preux, F., Arora, A., Moriyama, D., Kim, E., & Kim, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_13
Chapter 17. Treatment of Cannabis-Related Disorders
Brezing, C., Mitra, S., & LEVIN, F. R. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb17
Self-citation
Cannabisarznei zur Behandlung psychischer Störungen
Hoch, E., Preuss, U. W., & Pogarell, O. M. (2020) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-020-1271-z
The Safety of Phytocannabinoids and Cannabinoids in Clinical Practice
JAMES, S. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108583336.006
The use of psychoactive substances in the treatment of mental disorders
Karaś-Ruszczyk, K., Groblińska, K., Szczygieł, K., & Samochowiec, J. (2021) · Alcoholism and Drug Addiction · doi:10.5114/ain.2021.111791
Literaturverzeichnis zu Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkankungen, 9. Auflage
(2013) · Elsevier eBooks · doi:10.1016/b978-3-437-24905-1.16001-0
References
Fulton, B. S. (2014) · Wiley eBooks · doi:10.1002/9781118943670.refs
Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 13. Auflage
(2017) · Elsevier eBooks · doi:10.1016/b978-3-437-24909-9.16001-3
Cannabis
Leweke, F. M., & Hoyer, C. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_69

Authors: Levin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V.
Affiliations: New York State Psychiatric Institute (US)
Corresponding author: Levin, Frances R.
ORCID: Levin, Frances R.
Mariani, John J.
Cheng, Wendy
Nunes, Edward V.
Venue: Drug and Alcohol Dependence
Publisher: Elsevier BV
Published: 2011-07
Volume: 116
Issue: 1-3
Pages: 142-150
ISSN: 0376-8716 (ISSN-L)
DOI: 10.1016/j.drugalcdep.2010.12.010
PMC: PMC3154755
OpenAlex: W1979308736
Cited by: 232
References: 64
Citations by year: 2026: 12 · 2025: 7 · 2024: 17 · 2023: 15 · 2022: 25 · 2021: 15 · 2020: 13 · 2019: 12 · 2018: 23 · 2017: 11 · 2016: 14 · 2015: 19 · 2014: 20 · 2013: 9 · 2012: 17
FWCI: 11.28
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Drug and Alcohol Dependence (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Public Health Service (K02 000465)
National Institute on Drug Abuse (K24DA022412, P50DA009236, K24DA029647, T32DA007294)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: dronabinol, cannabis use disorder, delta-9-tetrahydrocannabinol, treatment retention, withdrawal symptoms, motivational enhancement therapy, abstinence, drug safety and tolerability
MeSH terms: Adult, Cannabinoids, Marijuana Abuse, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Marijuana Smoking, Middle Aged, Placebos, Psychotherapy, Psychotropic Drugs, Substance Withdrawal Syndrome, Dronabinol, Behavior, Addictive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks